Noninvasive detection and monitoring of drug levels in blood

The company’s platform will be harnessed to pioneer innovative devices for noninvasive monitoring drug levels without the need for a single drop of patient blood. Future indications could include devices for drug management and testing

Proof of concept study

A first monitoring application was demonstrated in a proof-of-concept clinical study:

  • In the  clinical study, the initial monitoring application aimed to noninvasively and continuously monitor anesthesia levels in patients’ blood in real-time.
  • The study successfully demonstrated the capability of IR-MED’s technology to monitor the blood levels of 40 patients undergoing a short medical procedure, all of whom were receiving intravenous (IV) propofol.
  • Remarkably, this monitoring was accomplished without the need to withdraw a single drop of blood.”

The company, with suitable partners, will explore and develop future applications for its technology in this field. 

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.